IL17A and Miyoshi myopathy: Several mediators play essential roles in the MM angiogenic process, leading to tumour growth, invasion, and metastasis, according to extensive study; for example, increased levels of Interleukin-16 (IL-16) and IL-17 result in a poor MM prognosis [7].